VG Life Sciences Inc. Share Price Other OTC
Equities
VGLS
US91822T1016
Biotechnology & Medical Research
Sales 2013 | - | Sales 2014 | - | Capitalization | 2.23M 178M |
---|---|---|---|---|---|
Net income 2013 | -7M -559M | Net income 2014 | -6M -479M | EV / Sales 2013 | - |
Net Debt 2013 | 2.49M 199M | Net Debt 2014 | 3.83M 305M | EV / Sales 2014 | - |
P/E ratio 2013 |
-0.25
x | P/E ratio 2014 |
-0.31
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 31/12/16 |
Ana Gois
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 31/12/16 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |